Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 23% ± 6% | |
B cell | 7 studies | 20% ± 3% | |
natural killer cell | 5 studies | 17% ± 1% | |
endothelial cell of lymphatic vessel | 5 studies | 22% ± 6% | |
epithelial cell | 4 studies | 25% ± 2% | |
capillary endothelial cell | 4 studies | 20% ± 3% | |
ciliated cell | 4 studies | 22% ± 3% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 1% | |
plasmablast | 3 studies | 29% ± 11% | |
endothelial cell of vascular tree | 3 studies | 22% ± 8% | |
naive B cell | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of PRKD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3167.06 | 1445 / 1445 | 100% | 45.68 | 183 / 183 |
thymus | 100% | 5312.42 | 653 / 653 | 100% | 53.03 | 605 / 605 |
intestine | 100% | 3472.90 | 966 / 966 | 100% | 38.70 | 526 / 527 |
prostate | 100% | 4705.38 | 245 / 245 | 100% | 40.53 | 501 / 502 |
uterus | 100% | 4243.43 | 170 / 170 | 100% | 48.07 | 458 / 459 |
ovary | 100% | 3633.87 | 180 / 180 | 100% | 37.98 | 428 / 430 |
skin | 100% | 5933.61 | 1808 / 1809 | 100% | 31.80 | 470 / 472 |
bladder | 100% | 3320.00 | 21 / 21 | 99% | 46.56 | 501 / 504 |
lung | 100% | 5928.67 | 577 / 578 | 100% | 39.42 | 1150 / 1155 |
breast | 100% | 5277.49 | 459 / 459 | 99% | 39.99 | 1111 / 1118 |
kidney | 100% | 3331.49 | 89 / 89 | 99% | 32.80 | 895 / 901 |
stomach | 100% | 2712.01 | 359 / 359 | 99% | 38.13 | 284 / 286 |
pancreas | 98% | 2006.40 | 320 / 328 | 100% | 45.90 | 178 / 178 |
adrenal gland | 100% | 2046.72 | 258 / 258 | 96% | 24.54 | 221 / 230 |
liver | 97% | 1435.53 | 220 / 226 | 98% | 22.10 | 398 / 406 |
brain | 44% | 498.59 | 1163 / 2642 | 93% | 17.27 | 653 / 705 |
adipose | 100% | 4696.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 77.33 | 29 / 29 |
spleen | 100% | 9710.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 52.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.96 | 1 / 1 |
peripheral blood | 100% | 8422.86 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2464.58 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 1519.60 | 813 / 861 | 0% | 0 | 0 / 0 |
muscle | 51% | 578.67 | 407 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0001525 | Biological process | angiogenesis |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0070232 | Biological process | regulation of T cell apoptotic process |
GO_0007155 | Biological process | cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0002250 | Biological process | adaptive immune response |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0045743 | Biological process | positive regulation of fibroblast growth factor receptor signaling pathway |
GO_0061154 | Biological process | endothelial tube morphogenesis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_2000573 | Biological process | positive regulation of DNA biosynthetic process |
GO_2001028 | Biological process | positive regulation of endothelial cell chemotaxis |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0030949 | Biological process | positive regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKD2 |
Protein name | Protein kinase D2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) PRKD2 protein |
Synonyms | HSPC187 PKD2 |
Description | FUNCTION: Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress-induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion . May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression (By similarity). In response to oxidative stress, is phosphorylated at Tyr-438 and Tyr-717 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B . In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77 . Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation . During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens (By similarity). In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF-kappa-B-dependent pathway . During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors . In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane . Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis . In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN . Downstream of PRKCA, plays important roles in angiotensin-2-induced monocyte adhesion to endothelial cells . Plays a regulatory role in angiogenesis and tumor growth by phosphorylating a downstream mediator CIB1 isoform 2, resulting in vascular endothelial growth factor A (VEGFA) secretion . . |
Accessions | ENST00000601806.5 [Q9BZL6-2] M0QZ82 M0QXC6 ENST00000595515.5 [Q9BZL6-3] M0R346 ENST00000601605.5 ENST00000593363.1 A0JLT6 ENST00000291281.9 [Q9BZL6-1] ENST00000598633.1 M0QZC2 ENST00000597390.5 ENST00000600194.5 [Q9BZL6-2] Q9BZL6 ENST00000433867.5 [Q9BZL6-1] ENST00000595132.5 M0R2Z8 M0R012 ENST00000597641.1 |